Information:
Fel:
ID
38381
Beskrivning
A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01425996
Länk
https://clinicaltrials.gov/show/NCT01425996
Nyckelord
Versioner (1)
- 2019-10-14 2019-10-14 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
14 oktober 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Carcinoma, Hepatocellular NCT01425996
Eligibility Carcinoma, Hepatocellular NCT01425996
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Hepatocellular NCT01425996
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
females or males 20-70 years of age (inclusive)
boolean
C0001779 (UMLS CUI [1])
Liver carcinoma | Condition Other
Item
patients with histological confirmed hcc or other conditions
boolean
C2239176 (UMLS CUI [1])
C0348080 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0348080 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
Liver carcinoma Advanced Locally | Portal vein Tumor thrombus | Tumor thrombus Inappropriate Local Therapy
Item
patients with locally advanced hcc and pvtt that is not suitable for other local therapies
boolean
C2239176 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C1305775 (UMLS CUI [2,1])
C3163918 (UMLS CUI [2,2])
C3163918 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1517925 (UMLS CUI [3,3])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C1305775 (UMLS CUI [2,1])
C3163918 (UMLS CUI [2,2])
C3163918 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1517925 (UMLS CUI [3,3])
Inclusion criteria Additional
Item
other inclusion criteria also apply
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])
Pregnancy | Breast Feeding | Pregnancy, Planned | Childbearing Potential Contraceptive methods Absent
Item
females who are pregnant/lactating or planning to be pregnant, or patients of childbearing potential who are not using medically recognized method of contraception.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
Neoplasm Metastasis Extrahepatic
Item
patients with documented extrahepatic metastasis
boolean
C0027627 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
C1517058 (UMLS CUI [1,2])
Encephalopathy Stage | Tense ascites
Item
patients with stage iii-iv encephalopathy or tense ascites
boolean
C0085584 (UMLS CUI [1,1])
C1306673 (UMLS CUI [1,2])
C0741244 (UMLS CUI [2])
C1306673 (UMLS CUI [1,2])
C0741244 (UMLS CUI [2])
Local Therapy Liver carcinoma | Systemic therapy Liver carcinoma
Item
patients who have received any local or systemic therapy for hcc within 4 weeks prior to the initiation of study treatment
boolean
C1517925 (UMLS CUI [1,1])
C2239176 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C2239176 (UMLS CUI [2,2])
C2239176 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C2239176 (UMLS CUI [2,2])
Lipotecan
Item
patients who have received lipotecan® treatment prior to the initiation of study treatment
boolean
C2698966 (UMLS CUI [1])
Exclusion Criteria Additional
Item
other exclusion criteria also apply
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,2])